References
- Dai WS, Hsu MA, Itri LM. 1989. Safety of pregnancy after discontinuation of isotretinoin. Archives of Dermatology 125:362–365.
- Geiger JM, Baudin M Saurat JH. 1994. Teratogenic risk with etretinate and acitretin. Dermatology 189:109–116.
- Han JY, Choi JS, Chun JM, Park HD, Lee SY, Kim CH, et al 2009. Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. Journal of Obstetrics and Gynaecology 29:694–697.
- Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al 1985. Retinoic acid embryopathy. New England Journal of Medicine 313:837–841.
- Rosa FW, Wilk AL, Kelsey FO. 1986. Teratogen update: vitamin A congeners. Teratology 33:355–364.
- Teratology Society. 1991. Recommendations for isotretinoin use in women of childbearing potential. Teratology 44:1–6.